Column Dollar grins at big shorts - Reuters
| XAIR Stock | USD 0.42 0.05 13.51% |
Slightly above 56% of all Beyond Air's retail investors are looking to take a long position. The analysis of overall sentiment of trading Beyond Air stock suggests that some investors are interested at this time. Beyond Air's investing sentiment overview a quick insight into current market opportunities from investing in Beyond Air. Many technical investors use Beyond Air stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Beyond |
Column Dollar grins at big shorts Reuters
Read at news.google.com
 |
Beyond Air Fundamental Analysis
We analyze Beyond Air's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Air using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Air based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Beyond Air is currently under evaluation in target price category among its peers.
Beyond Air Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Beyond Air stock to make a market-neutral strategy. Peer analysis of Beyond Air could also be used in its relative valuation, which is a method of valuing Beyond Air by comparing valuation metrics with similar companies.
Peers
Beyond Air Related Equities
| TMCI | Treace Medical | 5.58 | ||||
| DCTH | Delcath Systems | 4.68 | ||||
| KIDS | Orthopediatrics Corp | 2.37 | ||||
| CVRX | CVRx | 1.85 | ||||
| RCEL | Avita Medical | 1.29 | ||||
| TELA | Tela Bio | 1.13 | ||||
| CLPT | Clearpoint Neuro | 0.53 | ||||
| NPCE | Neuropace | 0.50 | ||||
| ELMD | Electromed | 0.38 | ||||
| NARI | Inari Medical | 0.19 | ||||
| SGHT | Sight Sciences | 0.35 | ||||
| CTKB | Cytek Biosciences | 0.55 | ||||
| LUCD | Lucid Diagnostics | 1.18 | ||||
| TMDX | TransMedics | 1.41 | ||||
| LUNG | Pulmonx Corp | 2.19 |
Additional Tools for Beyond Stock Analysis
When running Beyond Air's price analysis, check to measure Beyond Air's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Air is operating at the current time. Most of Beyond Air's value examination focuses on studying past and present price action to predict the probability of Beyond Air's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Air's price. Additionally, you may evaluate how the addition of Beyond Air to your portfolios can decrease your overall portfolio volatility.